Transfemoral Tricuspid Valve Replacement In Patients With Tricuspid Regurgitation-30-day Results Of The Triscend Study

Dr. Sammy Elmariah, Director, Interventional Cardiology Research at Massachusetts General Hospital discusses his recent research “Transfemoral Tricuspid Valve Replacement In Patients With Tricuspid Regurgitation: 30-day Results Of The Triscend Study” which was recently presented at the 2021 American College of Cardiology’s annual scientific meeting.  

Dr. Sammy Elmariah graduated from the University of Pennsylvania School of Medicine and completed his internal medicine residency training at the Hospital of the University of Pennsylvania. He subsequently served as Chief Medical Resident at Lankenau Hospital. Dr. Elmariah completed his fellowship in cardiovascular medicine at the Mount Sinai Hospital in New York where he also served as Chief Fellow. While a fellow, he also completed a Masters in Public Health at the Harvard School of Public Health. Dr. Elmariah completed further fellowship training in interventional cardiology and structural heart disease at the Massachusetts General Hospital. Currently, Dr. Elmariah is an interventional cardiologist and structural heart disease specialist at the Massachusetts General Hospital and Assistant Professor of Medicine at the Harvard Medical School. In addition, he serves as the Director of Interventional Structural Heart Disease at the Boston VA Healthcare System. He is also the Associate Director of Trial Design at the Harvard Clinical Research Institute.His clinical interest is in the management of valvular heart disease, coronary artery disease, and adult congenital heart disease. He performs transcatheter valve replacement, percutaneous coronary interventions (stents), and transcatheter closure of patent foramen ovale (PFO) and atrial septal defects (ASD).Dr. Elmariah has a specific research interest in valvular heart disease. In addition to ongoing clinical investigation of valve calcification and the progression of aortic stenosis, Dr. Elmariah is evaluating the impact of transcatheter aortic valve replacement on myocardial metabolism and myocardial remodeling. Dr. Elmariah is an MGH Heart Center Hassenfeld Research Scholar and has been awarded the Jeremiah Stamler Distinguished Young Investigator Award and an American College of Cardiology Young Investigator Award.

Listen on Soundcloud.

Liked it? Take a second to support healthprofessionalradio on Patreon!


Leave a Reply

You must be logged in to post a comment.